Nisa Investment Advisors’s Emergent Biosolutions EBS Stock Holding History

Nisa Investment Advisors’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.15K	Hold	500	–	–	﹤0.01%	2494
2025 Q4	$6.18K	Buy	+500	New	+$5.36K	﹤0.01%	2399
2025 Q2	–	Sell	-30	Closed	-$146	–	3053
2025 Q1	$146	Sell	30 -87	-74%	-$720	﹤0.01%	2947
2024 Q4	$1.12K	Hold	117	–	–	﹤0.01%	2657
2024 Q3	$977	Sell	117 -81	-41%	-$736	﹤0.01%	2581
2024 Q2	$1.35K	Buy	+198	New	+$852	﹤0.01%	2448
2023 Q4	–	Sell	-670	Closed	-$2.28K	–	2674
2023 Q3	$2.28K	Sell	670 -8,000	-92%	-$44.3K	﹤0.01%	2337
2023 Q2	$63.7K	Hold	8,670	–	–	﹤0.01%	1664
2023 Q1	$90K	Sell	8,670 -63,100	-88%	-$763K	﹤0.01%	1530
2022 Q4	$848K	Buy	71,770 +63,058	+724%	+$976K	0.01%	957
2022 Q3	$183K	Sell	8,712 -21,458	-71%	-$597K	﹤0.01%	1299
2022 Q2	$936K	Buy	30,170 +680	+2%	+$23.2K	0.01%	844
2022 Q1	$1.21M	Buy	29,490 +620	+2%	+$27.3K	0.01%	804
2021 Q4	$1.35M	Sell	28,870 -2,650	-8%	-$120K	0.01%	755
2021 Q3	$1.58K	Buy	31,520 +2,000	+7%	+$121K	0.01%	770
2021 Q2	$1.86K	Sell	29,520 -1,100	-4%	-$70.7K	0.01%	735
2021 Q1	$2.85K	Buy	30,620 +1,200	+4%	+$123K	0.02%	623
2020 Q4	$2.64M	Sell	29,420 -800	-3%	-$73.4K	0.02%	622
2020 Q3	$3.12M	Buy	30,220 +1,050	+4%	+$113K	0.03%	489
2020 Q2	$2.31M	Sell	29,170 -3,077	-10%	-$229K	0.02%	549
2020 Q1	$1.87M	Sell	32,247 -30	-0.1%	-$1.73K	0.02%	550
2019 Q4	$1.74M	Sell	32,277 -1,338	-4%	-$72.6K	0.01%	688
2019 Q3	$1.76M	Buy	33,615 +4,920	+17%	+$229K	0.02%	691
2019 Q2	$1.39M	Hold	28,695	–	–	0.01%	739
2019 Q1	$1.45M	Sell	28,695 -500	-2%	-$29.5K	0.01%	713
2018 Q4	$1.73M	Hold	29,195	–	–	0.02%	604
2018 Q3	$1.92M	Hold	29,195	–	–	0.02%	682
2018 Q2	$1.47M	Hold	29,195	–	–	0.02%	697
2018 Q1	$1.54M	Sell	29,195 -2,775	-9%	-$138K	0.02%	682
2017 Q4	$1.49M	Sell	31,970 -4,900	-13%	-$206K	0.02%	697
2017 Q3	$1.49M	Hold	36,870	–	–	0.02%	681
2017 Q2	$1.24M	Sell	36,870 -500	-1%	-$15.4K	0.01%	753
2017 Q1	$1.08M	Sell	37,370 -7,330	-16%	-$223K	0.01%	796
2016 Q4	$1.47M	Buy	44,700 +7,500	+20%	+$225K	0.02%	703
2016 Q3	$1.17M	Buy	37,200 +14,300	+62%	+$416K	0.02%	750
2016 Q2	$644K	Hold	22,900	–	–	0.01%	900
2016 Q1	$832K	Hold	22,900	–	–	0.01%	818
2015 Q4	$916K	Hold	22,900	–	–	0.01%	763
2015 Q3	$652K	Buy	22,900 +1,000	+5%	+$33K	0.01%	871
2015 Q2	$722K	Buy	21,900 +5,700	+35%	+$177K	0.01%	898
2015 Q1	$466K	Sell	16,200 -4,300	-21%	-$123K	0.01%	1057
2014 Q4	$558K	Buy	20,500 +5,000	+32%	+$119K	0.01%	974
2014 Q3	$330K	Sell	15,500 -1,000	-6%	-$22.9K	﹤0.01%	1123
2014 Q2	$371K	Hold	16,500	–	–	0.01%	1123
2014 Q1	$417K	Buy	16,500 +1,000	+6%	+$25.3K	0.01%	1099
2013 Q4	$356K	Buy	+15,500	New	+$323K	0.01%	1126

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Nisa Investment Advisors's EBS Position: Q1 2026 in Review

Nisa Investment Advisors held its Emergent Biosolutions (EBS) position steady in Q1 2026 at 500 shares worth $4.15K. The position accounts for ﹤0.01% of the portfolio, ranked #2494.

Nisa Investment Advisors first reported a position in EBS in Q4 2013 and has held it in 46 quarters since. The position peaked at $3.12M in Q3 2020. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

Nisa Investment Advisors held 500 shares of Emergent Biosolutions worth $4.15K as of Q1 2026.
Nisa Investment Advisors left its Emergent Biosolutions share count unchanged in Q1 2026.
Emergent Biosolutions made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2494 holding.
Nisa Investment Advisors first reported a position in Emergent Biosolutions in Q4 2013 and has held it in 46 quarters since.
Nisa Investment Advisors's Emergent Biosolutions position peaked at $3.12M in Q3 2020.
190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.